Rebeca Fernandez-Ruiz

Rebeca Fernandez-Ruiz

Auto-generated profile, based on publicly available information

Rebeca Fernandez-Ruiz

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EVElaine Vieira
Elaine Vieira
Laura MarroquiLaura Marroqui
Laura Marroqui
AFAna Lucia C. Figueroa
Ana Lucia C. Figueroa
Beatriz MerinoBeatriz Merino
Beatriz Merino
RFRebeca Fernandez-Ruiz
Rebeca Fernandez-Ruiz
IQIvan Quesada
Ivan Quesada
Disruption of pancreatic clock genes impairs pancreatic beta-cell function, leading to the onset of diabetes. Despite the importance of pancreatic alpha-cells in the regulation of glucose homeostasis and in diabetes pathophysiology, nothing is known about the role of clock genes in these cells. Here, we identify the clock gene Rev-erb alpha as a new intracellular regulator of glucagon secretion. Rev-erb alpha down-regulation by siRNA (60–70% inhibition) in alphaTC1-9 cells inhibited low-glucose induced glucagon secretion (p<0.05) and led to a decrease in key genes of the exocytotic machinery. The Rev-erb alpha agonist GSK4112 increased glucagon secretion (1.6 fold) and intracellular calcium signals in alphaTC1-9 cells and mouse primary alpha-cells, whereas the Rev-erb alpha antagonist SR8278 produced the opposite effect. At 0.5 mM glucose, alphaTC1-9 cells exhibited intrinsic circadian Rev-erb alpha expression oscillations that were inhibited by 11 mM glucose. In mouse primary alpha-cells, glucose induced similar effects (p<0.001). High glucose inhibited key genes controlled by AMPK such as Nampt, Sirt1 and PGC-1 alpha in alphaTC1-9 cells (p<0.05). AMPK activation by metformin completely reversed the inhibitory effect of glucose on Nampt-Sirt1-PGC-1 alpha and Rev-erb alpha. Nampt inhibition decreased Sirt1, PGC-1 alpha and Rev-erb alpha mRNA expression (p<0.01) and glucagon release (p<0.05). These findings identify Rev-erb alpha as a new intracellular regulator of glucagon secretion via AMPK/Nampt/Sirt1 pathway.

1 May 2006 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
AAAna Alonso
Ana Alonso
RFRebeca Fernández
Rebeca Fernández
MMMaría Moreno
María Moreno
POPatricia Ordóñez
Patricia Ordóñez
HGHéctor González-Pardo
Héctor González-Pardo
CGCelestino González
Celestino González
Aging is associated with insulin resistance, which represents a common factor in age-related diseases. We aimed to determine the role of 17β-estradiol on insulin sensitivity and memory during aging using ovariectomized rats (2–26 months of age) treated with physiological doses of 17β-estradiol. Our results indicate a lack of effect of 17β-estradiol replacement on spatial memory assessed in a water maze. Conversely, estradiol treatment improved insulin sensitivity in aging rats. These data imply that relatively low doses of 17β-estradiol may have beneficial effects on glucose homeostasis due to the protective effects of estrogen. However, estradiol treatment used in the present study did not prevent memory impairment associated with aging.

28 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RFRebeca Fernandez-Ruiz
Rebeca Fernandez-Ruiz
EVElaine Vieira
Elaine Vieira
PGPablo Garcia-Roves
Pablo Garcia-Roves
RGRamon Gomis
Ramon Gomis
Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin signalling pathway. It has been demonstrated that PTP1B deletion protects against the development of obesity and Type 2 Diabetes, mainly through its action on peripheral tissues. However, little attention has been paid to the role of PTP1B in β-cells. Therefore, our aim was to study the role of PTP1B in pancreatic β-cells. Silencing of PTP1B expression in a pancreatic β-cell line (MIN6 cells) reveals the significance of this endoplasmic reticulum bound phosphatase in the regulation of cell proliferation and apoptosis. Furthermore, the ablation of PTP1B is able to regulate key proteins involved in the proliferation and/or apoptosis pathways, such as STAT3, AKT, ERK1/2 and p53 in isolated islets from PTP1B knockout (PTP1B −/−) mice. Morphometric analysis of pancreatic islets from PTP1B −/− mice showed a higher β-cell area, concomitantly with higher β-cell proliferation and a lower β-cell apoptosis when compared to islets from their respective wild type (WT) littermates. At a functional level, isolated islets from 8 weeks old PTP1B −/− mice exhibit enhanced glucose-stimulated insulin secretion. Moreover, PTP1B −/− mice were able to partially reverse streptozotocin-induced β-cell loss. Together, our data highlight for the first time the involvement of PTP1B in β-cell physiology, reinforcing the potential of this phosphatase as a therapeutical target for the treatment of β-cell failure, a central aspect in the pathogenesis of Type 2 Diabetes.

19 June 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
HFHugo Figueiredo
Hugo Figueiredo
AFAna Lucia C. Figueroa
Ana Lucia C. Figueroa
AGAinhoa Garcia
Ainhoa Garcia
RFRebeca Fernandez-Ruiz
Rebeca Fernandez-Ruiz
CBChristophe Broca
Christophe Broca
RGRamon Gomis
Ramon Gomis
Inhibition of tyrosine phosphatase PTP1B in mouse and human islets promotes islet revascularization and improves graft survival and function.

20 November 2017 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
GAGloria Aranda
Gloria Aranda
RFRebeca Fernandez‐Ruiz
Rebeca Fernandez‐Ruiz
MPMarta Palomo
Marta Palomo
MRMónica Romo
Mónica Romo
MMMireia Mora
Mireia Mora
FHFelicia Alexandra Hanzu
Felicia Alexandra Hanzu

27 September 2007 in Endocrinology
Verified
Journal Article
Open access
AAAna Alonso
Ana Alonso
MMMaría Moreno
María Moreno
POPatricia OrdóñeZ
Patricia OrdóñeZ
RFRebeca FernánDez
Rebeca FernánDez
CPCristina PérEz
Cristina PérEz
CGCelestino González
Celestino González
Aging is associated with a reduction in metabolic function, insulin resistance, increased incidence of neurodegenerative diseases, and memory or cognitive dysfunction. In aging females, loss of gonadal function determines the beginning of the period of reduced metabolic function. Estrogens have neuroprotective effects, but the mechanisms by which they exert these effects remain unclear. The effects of estradiol treatment on the activation of the insulin receptor substrate (IRS)-1 signaling pathway, the interactions between estrogen receptor (ER)-α and IRS-1 and the p85α subunit of phosphatidylinositol-3 kinase, together with the possible effects of estradiol treatment on glucose transporter-3 and -4 levels, were investigated in female rats. The level of expression of each glucose transporter was greater in control and estradiol-treated groups than in the ovariectomized group. Interactions of ERα46-IRS-1, ERα46-p85α, and p85α-IRS-1, as well as IRS-1 phosphorylation, appeared to increase with estradiol treatment. The results indicate that estradiol treatment improves some aspects of neuronal homeostasis that are affected by aging; this may indicate that estradiol has neuroprotective effects in female rats. Additional animal studies are required to clarify the neuroprotective role of estradiol in relation to other important molecules involved in the IRS-1-phosphatidylinositol-3 kinase signaling pathway.